Maspin and Nm23-H1 expression in colorectal cancer

Neoplasma

Volumn 57, Issue 2, 2010, Pages 95-101

  Pasz Walczak, G ^a   Salagacka, A ^a   Potemski, P ^a   Balcerczak, E ^a   Kordek, R ^a   Mirowski, M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Colorectal cancer; Immunohistochemistry; Maspin; Nm23 H1 nucleoside diphosphate kinase; Prognosis; Survival rate

Indexed keywords

MASPIN; NUCLEOSIDE DIPHOSPHATE KINASE A; NME1 PROTEIN, HUMAN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CELLULAR DISTRIBUTION; COLORECTAL CARCINOMA; CYTOPLASM; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE WALL; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ADENOCARCINOMA; COLORECTAL TUMOR; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; COLORECTAL NEOPLASMS; CYTOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROGNOSIS; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953646597     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_02_95     Document Type: Article

References (26)

1. RUIZ P, GÜNTHERT U The cellular basis of metastasis. World J Urol 1996; 14: 141-50 doi:10.1007/BF00186893
2. NANNI O, VOLPI A, FRASSINETI GL, DE PAOLA F, GRANATO AM et al. Role of biological markers in the clinical outcome of colon cancer. Br J Cancer 2002; 87: 868-75 doi:10.1038/sj.bjc.6600569
3. ZOU Z, ANISOWICZ A, HENDRIX MJ, THOR A, NEVEU M et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994; 263: 526-9 doi:10.1126/science.8290962
4. SHENG S, CAREY J, SEFTOR EA, DIAS L, HENDRIX MJ et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A 1996; 93: 11669-74 doi:10.1073/pnas.93.21.11669
5. SHI HY, ZHANG W, LIANG R, KITTRELL F, TEMPLETON NS et al. Modeling human breast cancer metastasis in mice: maspin as a paradigm. Histol Histopathol 2003; 18: 201-6
6. MAASS N, TEFFNER M, RÖSEL F, PAWARESCH R, JONAT W et al. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 2001; 195: 321-6 doi:10.1002/path.948
7. BEECKEN WD, ENGL T, ENGELS K, BLUMENBERG C, OPPERMANN E et al. Clinical relevance of maspin expression in bladder cancer. World J Urol 2006; 24: 338-44 doi:10.1007/ s00345-006-0085-z
8. BOLTZE C Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis. Pathol Res Pract 2005; 200: 783-90 doi:10.1016/j.prp.2004.10.004
9. UMEKITA Y, YOSHIDA H Expression of maspin is upregulated during the progression of mammary ductal carcinoma. Histopathology 2003; 42: 541-5 doi:10.1046/ j.1365-2559.2003.01620.x
10. HIRAI K, KOIZUMI K, HARAGUCHI S, HIRATA T, MIKAMI I et al. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Ann Thorac Surg 2005; 79: 248-53 doi:10.1016/j.athoracsur.2004.06.118
11. SOOD AK, FLETCHER MS, GRUMAN LM, COFFIN JE, JABBARI S et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 2002; 8: 2924-32
12. KHALKHALI-ELLIS Z Maspin: the new frontier. Clin Cancer Res 2006; 12: 7279-83 doi:10.1158/1078-0432.CCR-06-1589
13. STEEG PS, BEVILACQUA G, KOPPER L, THORGEIRSSON UP, TALMADGE JE et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80: 200-4 doi:10.1093/jnci/80.3.200
14. TEE YT, CHEN GD, LIN LY, KO JL, WANG PH Nm23-H1: a metastasis-associated gene. Taiwan J Obstet Gynecol 2006; 45: 107-13 doi:10.1016/S1028-4559(09)60206-0
15. FAN Z, BERESFORD PJ, OH DY, ZHANG D, LIEBERMAN J Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003; 112: 659-72 doi:10.1016/S0092-8674(03)00150-8
16. BEVILACQUA G, SOBEL ME, LIOTTA LA, STEEG PS Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 1989; 49: 5185-90
17. FLØRENES VA, AAMDAL S, MYKLEBOST O, MAELANDSMO GM, BRULAND OS et al. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res 1992; 52: 6088-91
18. LEE CS, PIRDAS-ZIVCIC A nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Pathology 1994; 26: 448-52 doi:10.1080/00313029400169172
19. FERENC T, LEWIŃSKI A, LANGE D, NIEWIADOMSKA H, SYGUT J et al. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors. Pol J Pathol 2004; 55: 149-53
20. BERNEY CR, YANG JL, FISHER RJ, RUSSELL PJ, CROWE PJ Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival. World J Surg 1998; 22: 484-90 doi:10.1007/s002689900421
21. SARRIS M, LEE CS nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver. Eur J Surg Oncol 2001; 27: 170-4 doi:10.1053/ejso.2000.1070
22. LEE JC, LIN YJ, CHOW NH, WANG ST Reappraisal of the role of NM23-H1 in colorectal cancers. J Surg Oncol 2001; 76: 58-62 doi:10.1002/1096-9098(200101)76:1<58::AIDJSO1010> 3.0.CO;2-D
23. KAPITANOVIĆ S, CACEV T, BERKOVIĆ M, POPOVIĆ-HADZIJA M, RADOSEVIĆ S et al. nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma. J Clin Pathol 2004; 57: 1312-8 doi:10.1136/jcp.2004.017954
24. DURSUN A, AKYÜREK N, GÜNEL N, YAMAÇ D Prognostic implication of nm23-H1 expression in colorectal carcinomas. Pathology 2002; 34: 427-32 doi:10.1080/0031302021000009342
25. BETTSTETTER M, WOENCKHAUS M, WILD PJ, BLASZYK H, HARTMANN A et al. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J Pathol 2005; 205: 606-14 doi:10.1002/path.1732
26. DIETMAIER W, BETTSTETTER M, WILD PJ, WOENCKHAUS M, RÜMMELE P et al. Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer. Int J Cancer 2006; 118: 2247-54 doi:10.1002/ijc.21620